Results 181 to 190 of about 116,300 (353)

Acute abdominal pain assessment in the emergency department: The experience of a Greek university hospital [PDF]

, 2017
Apostolopoulou, Christina, Bampalis, Vasileios, Fafliora, Eleftheria, Gogos, Charalampos, Karanikola, Konstantina, Karanikolas, Menelaos, Kipourgos, George, Pantzaris, Nikolaos, Velissaris, Dimitrios   +8 more
core   +2 more sources

Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin

Pharmacotherapy, 2012
Jeremy W. Vandiver, T. Vondracek
semanticscholar   +1 more source

Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell's viper venom.

, 1978
Patricia Lindquist, Kazuo Fujikawa, Earl W. Davie   +2 more
openalex   +1 more source

Evaluation of the Use of a Medium Cut‐Off Dialyser Theranova 400 for Severe Metaldehyde Intoxication in Three Dogs: Dialytic Clearance and Therapeutic Response

Veterinary Medicine and Science, Volume 12, Issue 2, March 2026.
Three dogs with severe neurological signs from acute metaldehyde intoxication were treated with emergent haemodialysis using a medium cut‐off (MCO) dialyser. Neurological signs resolved within a single 4‐h session without adverse effects. Dialytic clearance of metaldehyde was 12.5 times higher than intrinsic clearance, demonstrating the clinical ...
Maxime Rodary, Claudia Iannucci, Andreas F. Lehner, Birgit Puschner, John P. Buchweitz, Alessio Vigani   +5 more
wiley   +1 more source

Discordant Partial Thromboplastin Time (PTT) vs Anti-Xa Heparin Activity [PDF]

, 2018
Jenna Khan, Wayne L. Chandler
openalex   +1 more source

Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance.

American Journal of Clinical Pathology, 2013
C. Takemoto, M. Streiff, K. Shermock, P. Kraus, Junnan Chen, J. Jani, T. Kickler   +6 more
semanticscholar   +1 more source

Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy [PDF]

, 2020
Matthew Lawlor, Aakriti Gupta, Lauren S. Ranard, Mahesh V. Madhavan, Jianhua Li, Andrew Eisenberger, Sahil A. Parikh, Sanjum S. Sethi, Amirali Masoumi   +8 more
openalex   +1 more source

Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical Trial

American Journal of Hematology, Volume 101, Issue 2, Page 242-254, February 2026.
ABSTRACT Iptacopan is a first‐in‐class, oral, selective inhibitor of complement factor B that has demonstrated positive efficacy across several complement‐driven diseases. Here we evaluate the efficacy and safety of iptacopan monotherapy in adult patients with primary immune thrombocytopenia (ITP) and primary cold agglutinin disease (CAD). We performed
Alexander Röth, Wilma Barcellini, Christine Ademokun, Junho Jang, Maria Luisa Lozano, David Valcarcel Ferreiras, Cristina Pascual‐Izquierdo, Shripad Chitnis, Sofiya Matviykiv, Alessandra Vitaliti, Chi Chen, Vasiliki Katsanou, Raghav Chawla, Hanny Al‐Samkari   +13 more
wiley   +1 more source

Houston, we have a problem: Coagulation concerns during long‐term spaceflight

Experimental Physiology, EarlyView.
Lewis Fall, Damian M. Bailey
wiley   +1 more source

Successful Catheter‐Directed Thrombolysis for a Patient With Intermediate‐High‐Risk Pulmonary Embolism: A Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Acute pulmonary embolism (PE) is a prevalent cardiovascular condition with significant mortality and morbidity. Treatment strategies vary according to risk stratification. While anticoagulation is sufficient for low‐risk patients, high‐risk cases often necessitate systemic thrombolysis (ST) or surgical embolectomy.
Mohammadreza Motazedian, Ahoura Salehi Nowbandegani, Zahra Mohammadi, Sina Bazmi   +3 more
wiley   +1 more source